IGC BIO INC. — Form D/A
IGC BIO INC. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2018-07-24. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-07-24
- Form: D/A
- Accession: 0001668051-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $1.6M
- Investors: 1
- Date of first sale: 2017-10-27
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-298608
Issuer
- Name: IGC BIO INC.
- CIK: 0001668051
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 50 CONGRESS STREET, BOSTON, MA, 02109
- Phone: 617-228-5720
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Tamar Erdfarb | Director | CAMBRIDGE, MA |
| Jeremy Wertheimer | Director | CAMBRIDGE, MA |
| Joseph Jacobson | Director | San Jose, CA |
| Oded Kadosh | Director | BOSTON, MA |
Other filings by this issuer (3)
More